Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 180

The DOI matches its Crossref record; 8 of the 8 references it cites were found in a registry or an index.

The Role of Inflammatory Cytokines in Cognition and Other Non-Motor Symptoms of Parkinson’s Disease

Open access
Menza, Matthew, DeFronzo Dobkin, Roseanne, Marin, Humberto, Mark, Margery H., Gara, Michael, Bienfait, Karina, Dicke, Allison, Kusnekov, Alex·2010·Psychosomatics

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/s0033-3182(10)70739-8

Cites

8 of 8 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 8 references

Research works printed but not linked: 23

  1. Jost, 2000, Costs in the treatment of parkinsonism, J Neurol, 247
  2. McKinlay, 2008, A profile of neuropsychiatric problems and their relationship to quality of life for Parkinson’s disease patients without dementia, Parkinsonism Relat Disord, 14, 37, 10.1016/j.parkreldis.2007.05.009 · DOI · Paper page
  3. McAfoose, 2009, Evidence for a cytokine model of cognitive function, Neurosci Biobehav Rev, 33, 355, 10.1016/j.neubiorev.2008.10.005 · DOI · Paper page
  4. Aarsland, 2003, Prevalence and characteristics of dementia in Parkinson disease: an 8-year prospective study, Arch Neurol, 60, 387, 10.1001/archneur.60.3.387 · DOI · Paper page
  5. Mrak, 2005, Potential Inflammatory biomarkers in Alzheimer’s disease, J Alz Dis, 8, 369
  6. Dik, 2005, Serum inflammatory proteins and cognitive decline in older persons, Neurology, 64, 1371, 10.1212/01.WNL.0000158281.08946.68 · DOI · Paper page
  7. Anisman, 2005, Cytokines as a precipitant of depressive illness: animal and human studies, Curr Pharm Des, 11, 963, 10.2174/1381612053381701 · DOI · Paper page
  8. Pickering, 2005, Actions of TNF-α on glutamatergic synaptic transmission in the central nervous system, Exp Physiol, 90, 663, 10.1113/expphysiol.2005.030734 · DOI · Paper page
  9. Boka, 1994, Immunocytochemical analysis of tumor necrosis factor and its receptors in Parkinson’s disease, Neurosci Lett, 172, 151, 10.1016/0304-3940(94)90684-X · DOI · Paper page
  10. Chen, 2005, Nonsteroidal antiinflammatory drug use and the risk for Parkinson’s disease, Ann Neurol, 58, 963, 10.1002/ana.20682 · DOI · Paper page
  11. Carvey, 2005, Intra-parenchymal injection of tumor necrosis factor-α and interleukin 1-β produces dopamine neuron loss in the rat, J Neural Transm, 112, 601, 10.1007/s00702-004-0222-z · DOI
  12. Nagatsu, 2006, Cellular and molecular mechanisms of Parkinson’s disease: neurotoxins, causative genes, and inflammatory cytokines, Cell Mol Neurobiol, 26, 781
  13. Menza, 2009, A controlled trial of antidepressants in patients with Parkinson’s disease and depression, Neurology, 72, 886, 10.1212/01.wnl.0000336340.89821.b3 · DOI · Paper page
  14. Hekler, 2007, Inflammatory markers in acute myocardial infarction patients: preliminary evidence of a prospective association with depressive symptoms, J Appl Biobehav Res, 12, 65, 10.1111/j.1751-9861.2007.00014.x · DOI
  15. Zuliani, 2007, Plasma cytokines profile in older subjects with late onset Alzheimer’s disease or vascular dementia, J Psychiatr Res, 41, 686, 10.1016/j.jpsychires.2006.02.008 · DOI · Paper page
  16. Bruunsgaard, 1999, A high plasma concentration of TNF-α is associated with dementia in centenarians, J Gerontol A Biol Sci Med Sci, 54, M357, 10.1093/gerona/54.7.M357 · DOI · Paper page
  17. Tobinick, 2006, TNF-α modulation for treatment of Alzheimer’s disease: a 6-month pilot study, Med Gen Med, 8, 25
  18. Tobinick, 2008, Rapid cognitive improvement in Alzheimer’s disease following perispinal etanercept administration, J Neuroinflammation, 5, 2, 10.1186/1742-2094-5-2 · DOI · Paper page
  19. Hayden, 2007, Does NSAID use modify cognitive trajectories in the elderly? The Cache County Study, Neurology, 69, 275, 10.1212/01.wnl.0000265223.25679.2a · DOI
  20. Szekely, 2004, Nonsteroidal antiinflammatory drugs for the prevention of Alzheimer’s disease: a systematic review, Neuroepidemiology, 23, 159, 10.1159/000078501 · DOI · Paper page
  21. Cummings, 1992, Depression and Parkinson’s disease, Am J Psychiatry, 149, 443, 10.1176/ajp.149.4.443 · DOI · Paper page
  22. Karlsen, 2000, Health related quality of life in Parkinson’s disease: a prospective longitudinal study, J Neurol Neurosurg Psychiatry, 69, 584, 10.1136/jnnp.69.5.584 · DOI · Paper page
  23. Cavadini, 2007, TNF-α suppresses the expression of clock genes by interfering with E-box-mediated transcription, PNAS, 104, 12843, 10.1073/pnas.0701466104 · DOI · Paper page

Cited by

See all 180

Metadata

Authors
Menza, M., DeFronzo Dobkin, R., Marin, H., Mark, M. H., Gara, M., Bienfait, K., Dicke, A., & Kusnekov, A.
Venue
Psychosomatics
Publisher
Elsevier BV
Published
2010-11
Volume
51
Issue
6
Pages
474-479
ISSN
0033-3182 (ISSN-L)
OpenAlex
W2000580759
Cited by
180
References
8
FWCI
3.99
Type
journal article
Language
en
Open access
green
Licence
  • www.elsevier.com/tdm/userlicense/1.0/ (tdm)
  • www.elsevier.com/legal/tdmrep-license (tdm)
Funders
National Institute of Neurological Disorders and Stroke (RO1NS043144)

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: The Role of Inflammatory Cytokines in Cognition and Other Non-Motor Symptoms of Parkinson’s Disease. https://app.cochat.ai/papers/10.1016/s0033-3182(10)70739-8
The paper
Menza, M., DeFronzo Dobkin, R., Marin, H., Mark, M. H., Gara, M., Bienfait, K., Dicke, A., & Kusnekov, A. (2010). The Role of Inflammatory Cytokines in Cognition and Other Non-Motor Symptoms of Parkinson’s Disease. Psychosomatics. https://doi.org/10.1016/s0033-3182(10)70739-8

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.